Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Plasma Fractionation by Product

• 5.1 Albumin
  • 5.1.1 Market Size and Forecast
• 5.2 Coagulation Factor Ix
  • 5.2.1 Market Size and Forecast
• 5.3 Coagulation Factor Viii
  • 5.3.1 Market Size and Forecast
• 5.4 Immunoglobulins
  • 5.4.1 Market Size and Forecast

Part 6. Global Market for Plasma Fractionation by Sector

• 6.1 Private Sector
  • 6.1.1 Market Size and Forecast
• 6.2 Public Sector
  • 6.2.1 Market Size and Forecast

Part 8. Global Market for Plasma Fractionation by Region

• 8.1 Asia-Pacific
  • 8.1.1 Market Size and Forecast
• 8.2 Europe
  • 8.2.1 Market Size and Forecast
• 8.3 North America
  • 8.3.1 Market Size and Forecast
• 8.4 Middle East And Africa (Mea)
  • 8.4.1 Market Size and Forecast
• 8.5 South America
  • 8.5.1 Market Size and Forecast

Part 8. Key Competitor Profiles

• 8.1 Baxter International Inc.
• 8.2 Bio Products Laboratory
• 8.3 Biotest AG
• 8.4 CSL Limited
• 8.5 Grifols, S.A.
• 8.6 Takeda Pharmaceutical Company Limited

*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis

• 9.1 Patent Statistics
• 9.2 Regional Analysis
• 9.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

The global plasma fractionation market is projected to grow at a compound annual growth rate (CAGR) of 5.66% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global plasma fractionation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The plasma fractionation market is segmented on the basis of product, and sector, and region. The plasma fractionation market is segmented as below:

By Product:
- albumin
- coagulation factor IX
- coagulation factor VIII
- immunoglobulins

By Sector:
- private sector
- public sector

By Region:
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America

The market research report covers the analysis of key stake holders of the plasma fractionation market. Some of the leading players profiled in the report include Baxter International Inc., Bio Products Laboratory, Biotest AG, CSL Limited, Grifols, S.A., Takeda Pharmaceutical Company Limited, among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global plasma fractionation market.
- To classify and forecast the global plasma fractionation market based on product, and sector, and region.
- To identify drivers and challenges for the global plasma fractionation market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global plasma fractionation market.
- To conduct pricing analysis for the global plasma fractionation market.
- To identify and analyze the profile of leading players operating in the global plasma fractionation market.

Why Choose This Report
- Gain a reliable outlook of the global plasma fractionation market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.